Xizhe Li

1.4k total citations · 1 hit paper
25 papers, 982 citations indexed

About

Xizhe Li is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xizhe Li has authored 25 papers receiving a total of 982 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xizhe Li's work include Circular RNAs in diseases (6 papers), RNA modifications and cancer (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Xizhe Li is often cited by papers focused on Circular RNAs in diseases (6 papers), RNA modifications and cancer (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Xizhe Li collaborates with scholars based in China, United States and Hong Kong. Xizhe Li's co-authors include Shengchao Xu, Lu Tang, Zhixiong Liu, Fan Fan, Ruimin Chang, Chunfang Zhang, Chaojun Duan, Chunfang Zhang, Jian Shi and Yu Xia and has published in prestigious journals such as Scientific Reports, Cell Death and Differentiation and Frontiers in Immunology.

In The Last Decade

Xizhe Li

25 papers receiving 974 citations

Hit Papers

Immunotherapy for glioma:... 2020 2026 2022 2024 2020 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xizhe Li China 14 585 337 263 222 219 25 982
Lu Tang China 14 501 0.9× 348 1.0× 295 1.1× 225 1.0× 180 0.8× 20 902
Shengchao Xu China 12 516 0.9× 335 1.0× 237 0.9× 289 1.3× 210 1.0× 16 902
Dauren Biyashev United States 15 484 0.8× 268 0.8× 92 0.3× 127 0.6× 171 0.8× 27 855
Zhong-Ping Chen China 24 855 1.5× 530 1.6× 212 0.8× 485 2.2× 106 0.5× 44 1.5k
Ye Song China 18 776 1.3× 507 1.5× 168 0.6× 134 0.6× 83 0.4× 44 1.1k
Lei Dong China 15 702 1.2× 376 1.1× 63 0.2× 144 0.6× 183 0.8× 41 1.0k
Sambad Sharma United States 16 850 1.5× 707 2.1× 372 1.4× 130 0.6× 176 0.8× 32 1.5k
Hongquan Yu China 16 732 1.3× 454 1.3× 77 0.3× 138 0.6× 119 0.5× 36 1.0k
Lun Gao China 14 337 0.6× 224 0.7× 173 0.7× 112 0.5× 97 0.4× 44 615

Countries citing papers authored by Xizhe Li

Since Specialization
Citations

This map shows the geographic impact of Xizhe Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xizhe Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xizhe Li more than expected).

Fields of papers citing papers by Xizhe Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xizhe Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xizhe Li. The network helps show where Xizhe Li may publish in the future.

Co-authorship network of co-authors of Xizhe Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xizhe Li. A scholar is included among the top collaborators of Xizhe Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xizhe Li. Xizhe Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Bo, Karrie Mei Yee Kiang, Fangkun Liu, et al.. (2025). Neutrophil Extracellular Trap Reprograms Cancer Metabolism to Form a Metastatic Niche Promoting Non‐Small Cell Lung Cancer Brain Metastasis. Advanced Science. 13(5). e08478–e08478. 1 indexed citations
2.
Zhou, Wolong, Yuanda Cheng, Linfeng Li, et al.. (2023). Cuproptosis Depicts Immunophenotype and Predicts Immunotherapy Response in Lung Adenocarcinoma. Journal of Personalized Medicine. 13(3). 482–482. 1 indexed citations
3.
Zhang, Nan, Hao Zhang, Zaoqu Liu, et al.. (2023). An artificial intelligence network‐guided signature for predicting outcome and immunotherapy response in lung adenocarcinoma patients based on 26 machine learning algorithms. Cell Proliferation. 56(4). e13409–e13409. 46 indexed citations
4.
Li, Linfeng, Qidong Cai, Zeyu Wu, et al.. (2023). Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction. Scientific Reports. 13(1). 2455–2455. 14 indexed citations
5.
Li, Xizhe, Ziyu Dai, Xianning Wu, et al.. (2022). The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma. Frontiers in Immunology. 13. 749241–749241. 34 indexed citations
6.
Luo, Ruiheng, Xizhe Li, & Dan Wang. (2022). Reprogramming Macrophage Metabolism and its Effect on NLRP3 Inflammasome Activation in Sepsis. Frontiers in Molecular Biosciences. 9. 917818–917818. 7 indexed citations
7.
Li, Xizhe, Wolong Zhou, & Dan Wang. (2022). Integrative bioinformatic analysis identified IFIT3 as a novel regulatory factor in psoriasis. Journal of Cellular Biochemistry. 123(12). 2066–2078. 3 indexed citations
8.
Xu, Xueming, Xizhe Li, Jian Shi, et al.. (2021). CCL13 is upregulated in alopecia areata lesions and is correlated with disease severity. Experimental Dermatology. 30(5). 723–732. 9 indexed citations
9.
Xu, Shengchao, Xizhe Li, Lu Tang, et al.. (2021). CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas. Frontiers in Molecular Biosciences. 8. 706949–706949. 27 indexed citations
10.
Li, Xizhe, Xianyu Liu, Deze Zhao, et al.. (2021). tRNA-derived small RNAs: novel regulators of cancer hallmarks and targets of clinical application. Cell Death Discovery. 7(1). 249–249. 36 indexed citations
11.
Shi, Wenwen, Bo Dou, Jun Wang, et al.. (2021). XBP1- IGFBP3 Signaling Pathway Promotes NSCLC Invasion and Metastasis. Frontiers in Oncology. 11. 654995–654995. 21 indexed citations
12.
Li, Xin, Xizhe Li, Wuyang Zhang, et al.. (2021). Factors and potential treatments of cough after pulmonary resection: A systematic review. Asian Journal of Surgery. 44(8). 1029–1036. 13 indexed citations
13.
Wang, Dan, et al.. (2020). The role of NLRP3 inflammasome in infection-related, immune-mediated and autoimmune skin diseases. Journal of Dermatological Science. 98(3). 146–151. 45 indexed citations
14.
Zhou, Wolong, Yang Gao, Yuanda Cheng, et al.. (2020). MICAL2 is a novel nucleocytoplasmic shuttling protein promoting cancer invasion and growth of lung adenocarcinoma. Cancer Letters. 483. 75–86. 32 indexed citations
15.
Xu, Shengchao, Lu Tang, Xizhe Li, Fan Fan, & Zhixiong Liu. (2020). Immunotherapy for glioma: Current management and future application. Cancer Letters. 476. 1–12. 501 indexed citations breakdown →
16.
Xu, Shengchao, et al.. (2019). Inflammasome inhibitors: promising therapeutic approaches against cancer. Journal of Hematology & Oncology. 12(1). 64–64. 67 indexed citations
17.
Ma, Hongyu, et al.. (2016). Lipopolysaccharide-Induced Nitric Oxide and Prolyl Oligopeptidase – Inhibitory Activities of Triterpenoids from Sanguisorba officinalis. Planta Medica International Open. 3(2). e39–e42. 1 indexed citations
18.
Yang, Junjie, Xiao-Fei Zhang, Zhen‐Ao Zhao, et al.. (2016). Regulatory roles of interferon-inducible protein 204 on differentiation and vasculogenic activity of endothelial progenitor cells. Stem Cell Research & Therapy. 7(1). 111–111. 3 indexed citations
19.
Lei, Wei, Xizhe Li, Xiaolin Wang, et al.. (2016). microRNA-206 is involved in survival of hypoxia preconditioned mesenchymal stem cells through targeting Pim-1 kinase. Stem Cell Research & Therapy. 7(1). 61–61. 28 indexed citations
20.
Li, Xizhe, et al.. (2015). Androgen Modulates Functions of Endothelial Progenitor Cells through Activated Egr1 Signaling. Stem Cells International. 2016(1). 7057894–7057894. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026